Merck is pursuing a focused growth strategy across Life Science, Healthcare, and Electronics. Through targeted acquisitions, investments, and customer-centric business models, the company is expanding its presence in dynamic technology markets. Discover how Merck leverages innovation in rare diseases, semiconductor materials, and digital platforms and what underpins its stable outlook for 2025.
K 2025 has once again set new standards. Despite economic uncertainties, the plastics and rubber industry in Düsseldorf demonstrated a high level of innovation and international presence. Circular economy, digitalization, and new material solutions shaped the trade fair, as did strategic partnerships and willingness to invest. A look back at eight intense days full of technical and conceptual...
Nestlé strengthened its growth momentum in the third quarter of 2025, despite a challenging environment. Confectionery and coffee proved to be particularly stable drivers. At the same time, the company is pushing ahead with strategic adjustments and expanding investments in high-margin areas. This overview of the current quarterly figures shows how the individual regions contributed to the...
In a strategic move, BASF is selling its majority stake in its global coatings business to Carlyle and QIA. The deal will bring the company a cash inflow of €5.8 billion and strengthen the independence of the business unit. BASF will retain a 40 percent stake and continue to actively support the future development of the business. The following article outlines the objectives of the transaction...
Interpack 2026 is fast approaching: from May 7 to 13, around 2,800 exhibitors will be presenting their innovations for packaging and processing in Düsseldorf. The focus will be on topics such as artificial intelligence, automation, sustainable materials, and new functionalities. Visitors can expect a comprehensive overview of current trends and practical solutions along the entire value chain...
BASF presented the progress of its “Winning Ways” strategy at a Capital Market Update in Antwerp. The chemical company confirmed its financial targets for 2028 and emphasized the importance of portfolio measures, disciplined capital allocation, and integrated value chains. Core businesses in particular are to be strengthened through efficiency improvements and investments. Read the full article to...
With its new cGMP facility in Zurich, Siegfried subsidiary Dinamiqs has reached an important milestone in the manufacture of viral vectors. The company combines research, development, and clinical and commercial production under one roof, thereby significantly expanding its capacities. At the same time, Dinamiqs is entering into a collaboration with Seal Therapeutics to advance the development of...
With its new Launch and Technology Center in Darmstadt in Germany, Merck has invested €160 million in the future of drug development. The facility combines research and commercial production to make small molecule therapies available more quickly. Modern technology, sustainable construction, and flexible production environments are designed not only to strengthen the company's competitiveness, but...
BASF Performance Materials has had all its European production sites certified according to REDcert2. The company now offers a comprehensive portfolio of sustainable high-performance plastics that replace fossil raw materials and reduce the carbon footprint. Engineering plastics, polyurethanes, TPU, and specialty polymers are now available to customers as certified mass balance solutions. For the...
With two focused acquisitions, Krones is further expanding its technological base in key market segments. The investments relate to both process technology and specialized solutions in can processing. The company is thus pursuing a clear strategy: expanding its portfolio through technological additions, tapping into new fields of application, and strengthening its position in global competition...
